Clinical Trial Update: A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer [Phase 2]

View source ↗

Summary

This document reports the withdrawal of a Phase II trial of proton pump inhibitors in combination with chemotherapy for metastatic head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Cancer of Head and Neck | Phase 2 | Status: WITHDRAWN